The rapid rise of GLP-1 weight-loss drugs has come with a raucous side show—a wave of copycat drugs unbound by drug patents. The knockoff surge was led by Hims & Hers Health, the telehealth firm that ...
Hims & Hers is shutting down Apostrophe, the skincare company it acquired in 2021, after a tumultuous month for the public ...
Hims & Hers (HIMS) went all-in on weight-loss drugs. It bet big on cheaper, compounded versions of blockbuster GLP-1 treatments like ...
After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...
The "Hims and Hers" commercial railed against the weight loss industry ... presented by researchers in Spain that shows significant potential for weight loss that comes in pill form. A new study finds ...
Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to ...
Below, Hers separates the fad from fact and busts some common weight loss myths. Willpower is a hopefully small ... Unfortunately, supplements aren't the magic pill they're often sold as. They're not ...
But with GLP-1 sales vanishing, Hims is left banking on generic weight-loss pills and its core business in hair-loss and ED treatments. While that business is solid, it doesn't justify the lofty ...
12don MSN
How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback